Rokit Healthcare Appoints CTO Nadan Lee to Accelerate U.S. Kidney and Cartilage Regeneration Efforts

Rokit Healthcare announced the appointment of Nadan Lee as its new chief technology officer. Lee will lead the company’s technology strategy for regenerative medicine. The focus will be on accelerating projects in kidney and cartilage regeneration. Rokit aims to expand its research and commercial activities in the United States. The hire reflects the firm’s ambition to capture a growing market for cell‑based therapies. Lee brings experience from previous roles in biotech and medical device development. The company expects the move to speed up product pipelines and regulatory progress. The announcement was reported by Seoul Economic Daily.